SRPL (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE updates Enhanced Surveillance Measure framework with new securities in Stage I, stage transitions, and consolidated ESM list effective … | |||||||||||||||
NSE updates Enhanced Surveillance Measure framework with new securities in Stage I, stage transitions, and consolidated ESM list effective September 9, 2025.
| |||||||||||||||
NSE announces changes to Enhanced Surveillance Measure including new securities additions, stage transitions, and 100% margin requirements … | |||||||||||||||
NSE announces changes to Enhanced Surveillance Measure including new securities additions, stage transitions, and 100% margin requirements effective September 1, 2025.
| |||||||||||||||
NSE cancels the planned suspension of trading in Shree Ram Proteins Limited securities effective August 28, 2025. | |||||||||||||||
NSE cancels the planned suspension of trading in Shree Ram Proteins Limited securities effective August 28, 2025.
| |||||||||||||||
NSE reverses trading restrictions on SRPL and restores daily trading from weekly trading after the company paid overdue Annual Listing Fees … | |||||||||||||||
NSE reverses trading restrictions on SRPL and restores daily trading from weekly trading after the company paid overdue Annual Listing Fees for FY 2024-25.
| |||||||||||||||
NSE suspends trading in Shree Ram Proteins Limited due to non-compliance with board composition requirements for two consecutive quarters. | |||||||||||||||
NSE suspends trading in Shree Ram Proteins Limited due to non-compliance with board composition requirements for two consecutive quarters.
| |||||||||||||||